| Trial ID: | L1158 |
| Source ID: | NCT01173848
|
| Associated Drug: |
Ergocalciferol
|
| Title: |
Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients
|
| Acronym: |
UPGRADE
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01173848/results
|
| Conditions: |
Chronic Kidney Disease Stage 3 and 4
|
| Interventions: |
DRUG: Ergocalciferol|DRUG: Cholecalciferol
|
| Outcome Measures: |
Primary: Subjects Achieving Normal Vitamin D Levels, within 24 weeks |
|
| Sponsor/Collaborators: |
Sponsor: The Cleveland Clinic
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
19
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-07
|
| Completion Date: |
2011-10-18
|
| Results First Posted: |
2017-04-04
|
| Last Update Posted: |
2017-04-04
|
| Locations: |
Cleveland Clinic, Cleveland, Ohio, 44195, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01173848
|
